The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2024
Filed:
Mar. 12, 2020
Applicant:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Inventors:
Harikiran Nistala, Tarrytown, NY (US);
Cristopher Van Hout, Tarrytown, NY (US);
Lyndon Mitnaul, Tarrytown, NY (US);
Anthony Marcketta, Tarrytown, NY (US);
Assignee:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/7105 (2006.01); A61K 33/30 (2006.01); C07K 14/435 (2006.01); C12Q 1/6876 (2018.01); C12Q 1/6897 (2018.01); G01N 33/66 (2006.01); G01N 33/68 (2006.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 33/30 (2013.01); C07K 14/435 (2013.01); C12Q 1/6876 (2013.01); C12Q 1/6897 (2013.01); G01N 33/66 (2013.01); G01N 33/6803 (2013.01); G01N 33/74 (2013.01); C12Q 2600/156 (2013.01); G01N 2333/62 (2013.01); G01N 2400/00 (2013.01);
Abstract
The present disclosure provides methods of treating subjects having increased serum glucose level and/or hyperglycemia, methods of identifying subjects having an increased risk of developing increased serum glucose level and/or hyperglycemia, and methods of detecting human Solute Carrier Family 39 Member 5 variant nucleic acid molecules and variant polypeptides.